Becker's Healthcare February 10, 2025
In December, Detroit-based Barbara Ann Karmanos Cancer Center became the first facility in the world to offer at-home liver cancer treatment with the TheraBionic P1, a device recently approved by the FDA.
Co-invented by Karmanos Cancer Institute President and CEO Boris Pasche, MD, PhD, the TheraBionic P1 uses radiofrequency electromagnetic fields at specific frequencies to target liver cancer tumors.
Dr. Pasche recently spoke to Becker’s about the device and what it means for the future of cancer care.
Editor’s note: Responses have been lightly edited for clarity and length.
Question: Can you briefly explain how the TheraBionic P1 works?
Dr. Boris Pasche: It is a small, portable device. The patient holds a spoon in their mouth. That’s...
Today's Sponsors
Today's Sponsor